ENTX (Entera Bio Ltd.) Earnings per share growth rate in current year
Entera Bio Ltd. (ENTX) monetizes innovative oral hormone delivery methods for osteoporosis therapy. Prospects depend on physician recognition of the effectiveness of replacing injections with tablets. Patent protection and strict FDA oversight limit the entry of new players. The YoY net income per share change ratio on the GURU.Markets chart demonstrates volatility, where the -98.60 metric reflects the company's current yield dynamics.
Comprehensive metric breakdowns and analytics for enterabio.com (ENTX)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
ENTX - Net Income|Expected Net Income Entera Bio Ltd.|ENTX - P/E Multiple|Future Price to Earnings Entera Bio|ENTX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ENTX|ENTX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Entera Bio|ENTX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months enterabio.com|ENTX - Earnings per share growth in current year|Net earnings per share growth forecast for next year Entera Bio Ltd.
Fundamental valuation:ENTX Entera Bio Corp
Relative EPS YoY dynamics are used to evaluate the effectiveness of Entera Bio Ltd. (ENTX). This indicator captures the percentage deviation of current earnings per share from the same value last year. The calculation allows for the rapid identification of any slowdown in the monetization rates of the innovative oral hormone platform. A positive trend confirms the commercial success of transitioning from injections to tablets for the treatment of osteoporosis. Stable growth in this metric signals a fundamental strengthening of the business.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal)|Perrigo Company PLC (PRGO) - Earnings per share growth rate in current year|ALVO - Earnings per share growth in current year|LQDA (Liquidia Inc.) - Earnings per share growth this year|GLPG (Galapagos NV) - Net earnings per share growth this year|ANIP: Net earnings per one share growth for the current year|MNKD (MannKind) - Earnings growth in current year|Earnings per share growth rate in current year Amphastar Pharmaceuticals Inc AMPH|Earnings per share growth in current year Pacira (PCRX)|SPRY (ARS Corp) - Earnings per share increase in current year|Earnings growth in current year TBPH (Theravance Biopharma)|Earnings growth in current year aquestive.com AQST|SCPH: Net earnings per share growth this year|Earnings per share increase in current year TECX (Tectonic Therapeutic, Inc.)|TNXP: Earnings growth in current year|SXTC (China SXT Pharmaceuticals, Inc.) - Earnings per share growth in current year|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth in current year|bioharvest.com (BHST) - Expected net earnings per share growth this year|Earnings per share growth in current year eXoZymes (EXOZ)|ORMP - Earnings per share growth rate in current year|MindWalk - Net earnings per share growth this year|Earnings per share increase in current year ABVC|CPIX - Earnings per share growth in current year|QNTM: Earnings per share growth in current year|FGEN (FibroGen) - Net earnings per share growth this year|TELO: Net earnings per one share growth for the current year|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Earnings per share growth this year SNYR (Synergy CHC Corporation)|Net earnings per share growth this year RLYB (Rallybio Corporation)|Expected net earnings per share growth this year lexariabioscience.com|Earnings growth in current year PULM (Pulmatrix)|Pheton Holdings Limited (PTHL) - Earnings per share growth rate in current year|APM - Earnings per share growth in current year|LYRA (Lyra Therapeutics Inc) - Earnings per share growth this year|IBO (Impact BioMedical) - Net earnings per share growth this year|TNFA: Net earnings per one share growth for the current year|Net earnings per share growth this year YCBD|Earnings per share growth this year PRFX (PainReform Ltd)|Earnings per share growth in current year Altamira Therapeutics (CYTO)|LIPO: Earnings per share trend in current year|Earnings growth in current year OPTN (OptiNose, Inc.)|Earnings per share increase in current year PIRS|Procaps - Earnings growth in current year|PTPI - Earnings growth in current year|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN Inc. - Earnings per share increase in current year|Earnings per share growth in current year TFF Pharmaceuticals
